QBR106638

• Research type

  Research Study

• Full title

  A phase I study to assess the bioavailability of AK106-001616 in healthy volunteers

• IRAS ID

  80830

• Contact name

  Philip Evans

• Contact email

  Phil.Evans@quotientclinical.com

• Sponsor organisation

  Asahi Kasei Pharma Corporation

• Eudract number

  2011-000574-54

• Research summary

  Research Summary not published at request of researcher

• REC name

  North West - Greater Manchester Central Research Ethics Committee

• REC reference

  11/IE/0083

• Date of REC Opinion

  30 Jun 2011

• REC opinion

  Further Information Favourable Opinion